North America Mrna Therapeutics Contract Development & Manufacturing Market Size & Outlook
North America mrna therapeutics contract development & manufacturing market, 2021-2030 (US$M)
Related Markets
North America mrna therapeutics contract development & manufacturing market highlights
- The North America mrna therapeutics contract development & manufacturing market generated a revenue of USD 1,533.0 million in 2023.
- The market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating indication in 2023.
- Infectious Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 1,533.0 million |
| Market revenue in 2030 | USD 3,228.0 million |
| Growth rate | 11.2% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Infectious Diseases |
| Historical data covered | 2021 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Diseases |
| Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
Other key industry trends
- In terms of revenue, North America region accounted for 37.0% of the global mrna therapeutics contract development & manufacturing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 3,228.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Contract Development & Manufacturing Market Scope
MRNA Therapeutics Contract Development & Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America mrna therapeutics contract development & manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
The market is driven by the presence of established contract development & manufacturing organizations (CDMOs), increasing number of clinical trials, and growing prevalence of infectious diseases, respiratory diseases, and cardiovascular & cerebrovascular diseases in North America.
For instance, in January 2023, the Cystic Fibrosis Foundation announced investing nearly USD 15 million in ReCode Therapeutics to develop mRNA therapy for cystic fibrosis irrespective of mutations. The foundation joined other institutions & investors participating in the company’s Series B financing of USD 210 million.
In February 2024, Arcturus Therapeutics and CSL announced the results of a followup on the ARCT-154 booster dose Phase 3 study. It was the first sa-mRNA COVID-19 vaccine approved globally and can be administered at one-sixth the dose of Comirnaty (5 μg vs 30 μg).
Reasons to subscribe to North America mrna therapeutics contract development & manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America mrna therapeutics contract development & manufacturing market databook
-
Our clientele includes a mix of mrna therapeutics contract development & manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into North America mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America mrna therapeutics contract development & manufacturing market size, by country, 2021-2030 (US$M)
North America MRNA Therapeutics Contract Development & Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
